help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 72, No. 2 492-495
doi:10.1210/jcem-72-2-492
Copyright © 1991 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PONTIROLI, A. E.
Right arrow Articles by POZZA, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PONTIROLI, A. E.
Right arrow Articles by POZZA, G.

Growth Hormone (GH) Autofeedback on GH Response to GH-Releasing Hormone. Role of Free Fatty Acids and Somatostatin

A. E. PONTIROLI, R. LANZI, L. D. MONTI, E. SANDOLI and G. POZZA

Istituto Scientifico San Raffaele, Clinica Medica, Universita di Milano Milan, Italy

Address all correspondence and requests for reprints to: A. E. Pontiroli, Istituto San Raffaele, Via Olgettina 60, 20132 Milan, Italy.

Methionyl-GH (met-GH) infusions inhibit the GH response to GH-releasing hormone (GHRH). Met-GH infusions induce lipolysis with a rise of plasma FFA that are known to suppress GH release, but the met-GH inhibition of the GH response to GHRH occurs also when lipolysis is pharmacologically blocked by acipimox. In addition, the inhibition of GH release might be due to an enhanced release of hypothalamic somatostatin. The aim of this study was to evaluate the effect of a met-GH infusion on the GH response to GHRH when lipolysis and hypothalamic somatostatin release are pharmacologicallyblocked. Twelve normal subjects, randomly allocated to two groups (A and B), received GHRH (50 µg. iv) at 1300 h after a 4-h saline infusion or met-GH infusion (80 ng/kg·min). To block lipolysis and hypothalamic somatostatin release, subjects in group B received acipiinox, an antilipolytic agent (500 mg), and pyridostigmine, an acetylcholinesterase inhibitor (60 mg), during the 6 h before iv GHRH. GHRH induced a clear GH release during saline infusion in both groups, significantly higher in group B (43.6 w± 4.8 µg/L) than in group A (20.1 ± 6.1 µg/L; P < 0.02 vs. A), and only a slight increase during met-GH infusions (10.4 ± 4.1 µg/L in group A; 16.7 ± 4.2 µg/L in group B; P = NS).

These data indicate that the GH response to GHRH is inhibited by met-GH infusions when peripheral lipolysis and hypothalamic somatostatin release are pharmacologically blocked, suggesting the possibility of autoinhibition of GH at the pituitary level.

Received April 2, 1990.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
B. Roelands, M. Goekint, E. Heyman, M. F. Piacentini, P. Watson, H. Hasegawa, L. Buyse, F. Pauwels, G. De Schutter, and R. Meeusen
Acute norepinephrine reuptake inhibition decreases performance in normal and high ambient temperature
J Appl Physiol, July 1, 2008; 105(1): 206 - 212.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. Stokes, M. Nevill, J. Frystyk, H. Lakomy, and G. Hall
Human growth hormone responses to repeated bouts of sprint exercise with different recovery periods between bouts
J Appl Physiol, October 1, 2005; 99(4): 1254 - 1261.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
X.-D. Qu, I. T. Gaw Gonzalo, M. Y. Al Sayed, P. Cohan, P. D. Christenson, R. S. Swerdloff, D. F. Kelly, and C. Wang
Influence of Body Mass Index and Gender on Growth Hormone (GH) Responses to GH-Releasing Hormone Plus Arginine and Insulin Tolerance Tests
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1563 - 1569.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Endocr. Rev., February 1, 2005; 26(1): 114 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. S. Bonert, J. D. Elashoff, P. Barnett, and S. Melmed
Body Mass Index Determines Evoked Growth Hormone (GH) Responsiveness in Normal Healthy Male Subjects: Diagnostic Caveat for Adult GH Deficiency
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3397 - 3401.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Ozata, C. Dieguez, and F. F. Casanueva
The Inhibition of Growth Hormone Secretion Presented in Obesity Is Not Mediated by the High Leptin Levels: A Study in Human Leptin Deficiency Patients
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 312 - 316.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. A. Stokes, M. E. Nevill, G. M. Hall, and H. K. A. Lakomy
Growth hormone responses to repeated maximal cycle ergometer exercise at different pedaling rates
J Appl Physiol, February 1, 2002; 92(2): 602 - 608.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Lanzi, M. Losa, G. Mignogna, A. Caumo, and A. E. Pontiroli
The Control on Growth Hormone Release by Free Fatty Acids Is Maintained in Acromegaly
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1234 - 1238.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
A. Giustina and J. D. Veldhuis
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human
Endocr. Rev., December 1, 1998; 19(6): 717 - 797.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Cordido, T. Fernandez, T. Martinez, A. Peñalva, R. Peinó, F. F. Casanueva, and C. Dieguez
Effect of Acute Pharmacological Reduction of Plasma Free Fatty Acids on Growth Hormone (GH) Releasing Hormone-Induced GH Secretion in Obese Adults with and without Hypopituitarism
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4350 - 4354.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
I. M. Chapman, M. L. Hartman, S. S. Pezzoli, F. E. Harrell Jr., R. L. Hintz, K. G. M. M. Alberti, and M. O. Thorner
Effect of Aging on the Sensitivity of Growth Hormone Secretion to Insulin-Like Growth Factor-I Negative Feedback
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2996 - 3004.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Leal-Cerro, L. M. Jimenez, R. Astorga, I. Fernandez-Lopez, C. Dieguez, and F. F. Casanueva
Acute Pharmacological Reduction of Plasma Free Fatty Acids Enhances the Growth Hormone (GH)-Releasing Hormone-Mediated GH Secretion in Patients with Cushing's Syndrome
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3165 - 3168.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Lanzi, M. F. Manzoni, A. C. Andreotti, M. E. Malighetti, E. Bianchi, L. P. Sereni, A. Caumo, L. Luzi, and A. E. Pontiroli
Evidence for an Inhibitory Effect of Physiological Levels of Insulin on the Growth Hormone (GH) Response to GH-Releasing Hormone in Healthy Subjects
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2239 - 2243.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society